The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic
Open accessAbstract
Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic, a Society of Toxicology Contemporary Concepts in Toxicology (CCT) workshop was held on March 11, 2017. The meeting was convened to raise awareness of metabolic syndrome and its associated diseases and serve as a melting pot with scientists of multiple disciplines (eg, toxicologists, clinicians, regulators) so as to spur research and understanding of this condition. The criteria for metabolic syndrome include obesity, dyslipidemia (low high-density lipoprotein and/or elevated triglycerides), elevated blood pressure, and alterations in glucose metabolism. It can lead to a greater potential of type 2 diabetes, lipid disorders, cardiovascular disease, hepatic steatosis, and other circulatory disorders. Although there are no approved drugs specifically for this syndrome, many drugs target diseases associated with this syndrome thus potentially increasing the likelihood of drug-drug interactions. There is currently significant research focusing on understanding the key pathways that control metabolism, which would be likely targets of risk factors (eg, exposure to xenobiotics, genetics) and lifestyle factors (eg, microbiome, nutrition, and exercise) that contribute to metabolic syndrome. Understanding these pathways could also lead to the development of pharmaceutical interventions. As individuals with metabolic syndrome have signs similar to that of toxic responses (eg, oxidative stress and inflammation) and organ dysfunction, these alterations should be taken into account in drug development. With the increasing frequency of metabolic syndrome in the general population, the idea of a "normal" individual may need to be redefined. This paper reports on the substance and outcomes of this workshop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“In Dr Ratner’s presentation, he showed research that suggested metformin reduced the risk of metabolic syndrome in patients with elevated fasting plasma glucose concentrations, although lifestyle changes were more effective (Knowler et al., 2002).”
BackgroundA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 1×
“Common triggers, such as metabolic stress responses to chronic caloric excess and resultant cell death, may trigger inflammation in each of these sites (Kraja et al., 2014; Sell et al., 2012; Strowig et al., 2012).”
BackgroundEarly life risk factors for obesity in childhood: cohort study
Reilly, J. J., Armstrong, J., Dorosty, A. R., Emmett, P. M., Ness, A., Rogers, I., Steer, C., & Sherriff, A. (2005) · BMJ · doi:10.1136/bmj.38470.670903.e0 · Cited by 1,675
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Genetic and Environmental Factors in Relative Body Weight and Human Adiposity
Maes, H. H. M., Neale, M. C., & Eaves, L. J. (1997) · Behavior Genetics · doi:10.1023/a:1025635913927 · Cited by 1,515
The Body-Mass Index of Twins Who Have Been Reared Apart
Stunkard, A. J., Harris, J. R., Pedersen, N. L., & McClearn, G. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222102 · Cited by 1,286
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070
Gut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860
Fraser, A., Tilling, K., Macdonald-Wallis, C., Sattar, N., Brion, M.-J., Benfield, L., Ness, A., Deanfield, J., Hingorani, A., Nelson, S. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.906081 · Cited by 486
DDT and breast cancer in young women: new data on the significance of age at exposure
Cohn, B. A., Wolff, M. S., Cirillo, P. M., & Sholtz, R. I. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10260 · Cited by 477
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Warrier, M., Shih, D. M., Burrows, A. C., Ferguson, D., Gromovsky, A. D., Brown, A. L., Marshall, S., McDaniel, A., Schugar, R. C., Wang, Z., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.036 · Cited by 414 · cited 4×
“He described some of his current mechanistic studies that further show the association of circulating TMAO with obesity, and type 2 diabetes, wherein TMAO promotes insulin resistance, promotes atherosclerosis by decreasing reverse cholesterol transport and increases forward cholesterol transport.”
BackgroundInfluentialTelevision viewing, bedroom television, and sleep duration from infancy to mid-childhood
Cespedes, E. M., Gillman, M. W., Kleinman, K., Rifas-Shiman, S. L., Redline, S., & Taveras, E. M. (2014) · Pediatrics · doi:10.1542/peds.2013-3998 · Cited by 219
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
Organizational actions of metabolic hormones
Bouret, S. G. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.01.001 · Cited by 52
Self-citation
Research works printed but not linked: 42
- Anuurad, 2009, Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease, Metab. Syndr. Relat. Disord., 7, 401, 10.1089/met.2008.0096 · DOI
- Bray, 2016, NIH working group report-using genomic information to guide weight management: From universal to precision treatment, Obesity (Silver Spring), 24, 14, 10.1002/oby.21381 · DOI · Paper page
- Cano-Sancho, 2017, Association between exposure to p,p′-DDT and its metabolite p,p′-DDE with obesity: Integrated systematic review and meta-analysis, Environ. Health Perspect., 10.1289/EHP527 · DOI
- Cunningham, 2014, Incidence of childhood obesity in the United States, N. Engl. J. Med., 370, 1660, 10.1056/NEJMoa1309753 · DOI · Paper page
- Desai, 2015, Epigenomics, gestational programming and risk of metabolic syndrome, Int. J. Obes. (Lond.), 39, 633, 10.1038/ijo.2015.13 · DOI · Paper page
- Eskenazi, 2009, The Pine River statement: Human health consequences of DDT use, Environ. Health Perspect., 117, 1359, 10.1289/ehp.11748 · DOI · Paper page
- Eskenazi, 2006, In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children, Pediatrics, 118, 233, 10.1542/peds.2005-3117 · DOI · Paper page
- Evangelou, 2016, Exposure to pesticides and diabetes: A systematic review and meta-analysis, Environ. Int., 91, 60, 10.1016/j.envint.2016.02.013 · DOI · Paper page
- Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 528, 262, 10.1038/nature15766 · DOI · Paper page
- Fromenty, 2013, Drug-induced liver injury in obesity, J. Hepatol., 58, 824, 10.1016/j.jhep.2012.12.018 · DOI
- Gaillard, 2015, Maternal weight gain in different periods of pregnancy and childhood cardio-metabolic outcomes. The Generation R Study, Int. J. Obes. (Lond.), 39, 677, 10.1038/ijo.2014.175 · DOI · Paper page
- Glavas, 2010, Early overnutrition results in early-onset arcuate leptin resistance and increased sensitivity to high-fat diet, Endocrinology, 151, 1598, 10.1210/en.2009-1295 · DOI · Paper page
- Grundy, 2008, Metabolic syndrome pandemic, Arterioscler. Thromb. Vasc. Biol., 28, 629, 10.1161/ATVBAHA.107.151092 · DOI · Paper page
- Herrera-Portugal, 2005, Environmental pathways of exposure to DDT for children living in a malarious area of Chiapas, Mexico, Environ. Res., 99, 158, 10.1016/j.envres.2005.03.010 · DOI · Paper page
- Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat. Med., 19, 576, 10.1038/nm.3145 · DOI · Paper page
- Korem, 2015, Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples, Science, 349, 1101, 10.1126/science.aac4812 · DOI · Paper page
- Kraja, 2014, Pleiotropic genes for metabolic syndrome and inflammation, Mol. Genet. Metab., 112, 317, 10.1016/j.ymgme.2014.04.007 · DOI
- Kramer, 2016, Geography of adolescent obesity in the U.S., 2007–2011, Am. J. Prev. Med., 51, 898, 10.1016/j.amepre.2016.06.016 · DOI
- La Merrill, 2014, Perinatal exposure of mice to the pesticide DDT impairs energy expenditure and metabolism in adult female offspring, PLoS One, 9, e103337., 10.1371/journal.pone.0103337 · DOI · Paper page
- La Merrill, 2016, Perinatal DDT exposure induces hypertension and cardiac hypertrophy in adult mice, Environ. Health Perspect., 124, 1722, 10.1289/EHP164 · DOI
- Lim, 2009, Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance, PLoS One, 4, e5186., 10.1371/journal.pone.0005186 · DOI · Paper page
- Lumeng, 2013, Innate immune activation in obesity, Mol. Aspects Med., 34, 12, 10.1016/j.mam.2012.10.002 · DOI
- Malagon, 2013, Adipobiology for novel therapeutic approaches in metabolic syndrome, Curr. Vasc. Pharmacol., 11, 954, 10.2174/15701611113116660170 · doi:10.2174/15701611113116660170
- Marotz, 2016, Treating obesity and metabolic syndrome with fecal microbiota transplantation, Yale J. Biol. Med., 89, 383
- Montgomery, 2015, Mitochondrial dysfunction and insulin resistance: An update, Endocr. Connect., 4, R1, 10.1530/EC-14-0092 · DOI · Paper page
- Mullins, 2017, Acute sleep restriction increases dietary intake in preschool-age children, J. Sleep Res., 26, 48, 10.1111/jsr.12450 · DOI
- Nassir, 2014, Role of mitochondria in nonalcoholic fatty liver disease, Int. J. Mol. Sci., 15, 8713, 10.3390/ijms15058713 · DOI · Paper page
- Park, 2008, A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians, Diabetologia, 51, 602, 10.1007/s00125-008-0933-z · DOI
- Park, 2016, Body burden of persistent organic pollutants on hypertension: A meta-analysis, Environ. Sci. Pollut. Res. Int., 23, 14284, 10.1007/s11356-016-6568-6 · DOI
- Plagemann, 2006, Perinatal nutrition and hormone-dependent programming of food intake, Horm. Res, 65, 83
- Pravenec, 2007, Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains, Genome Res., 17, 1319, 10.1101/gr.6548207 · DOI
- Sell, 2012, Adaptive immunity in obesity and insulin resistance, Nat. Rev. Endocrinol., 8, 709, 10.1038/nrendo.2012.114 · DOI · Paper page
- Song, 2016, Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: A systematic review and meta-analysis, J. Diabetes, 8, 516, 10.1111/1753-0407.12325 · DOI · Paper page
- Sunny, 2017, Mitochondrial adaptation in nonalcoholic fatty liver disease: Novel mechanisms and treatment strategies, Trends Endocrinol. Metab., 28, 250, 10.1016/j.tem.2016.11.006 · DOI · Paper page
- Tang-Peronard, 2011, Endocrine-disrupting chemicals and obesity development in humans: A review, Obes. Rev., 12, 622, 10.1111/j.1467-789X.2011.00871.x · DOI · Paper page
- Tariq, 2016, Non-alcoholic fatty pancreatic disease: A review of literature, Gastroenterol. Res., 9, 87, 10.14740/gr731w · DOI
- Tornatore, 2012, The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation, Trends Cell Biol., 22, 557, 10.1016/j.tcb.2012.08.001 · DOI · Paper page
- Toubal, 2013, Genomic and epigenomic regulation of adipose tissue inflammation in obesity, Trends Endocrinol. Metab., 24, 625, 10.1016/j.tem.2013.09.006 · DOI
- Wang, 2016, Weight gain in infancy and overweight or obesity in childhood across the gestational spectrum: A prospective birth cohort study, Sci. Rep., 6, 29867., 10.1038/srep29867 · DOI
- Wang, 2016, Do environmental pollutants increase obesity risk in humans?, Obes. Rev., 17, 1179, 10.1111/obr.12463 · DOI
- Whitaker, 1997, Predicting obesity in young adulthood from childhood and parental obesity, N. Engl. J. Med, 337, 869, 10.1056/NEJM199709253371301 · DOI · Paper page
- Wolff, 2007, Pharmacokinetic variability and modern epidemiology: The example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort, Cancer Epidemiol. Biomarkers Prev., 16, 1925, 10.1158/1055-9965.EPI-07-0394 · DOI
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Metadata
- Authors
- Mendrick, D. L., Diehl, A. M., Topor, L. S., Dietert, R. R., Will, Y., La Merrill, M. A., Bouret, S., Varma, V., Hastings, K. L., Schug, T. T., Emeigh Hart, S. G., & Burleson, F. G.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-02
- Volume
- 162
- Issue
- 1
- Pages
- 36-42
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2765151872
- Cited by
- 246
- References
- 19
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- National Institute of Environmental Health Sciences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.